Intern, Biology

Intern, Biology

Cambridge, MA

Requisition Number: 25-Intern8

What will you do?

• Work closely with scientists to advance early-stage drug discovery program as a member of the biology team
• In collaboration with your supervisor, learn and develop skills to design and execute experiments to answer biological questions relevant to the targets of interest
• Participate in project and cross-functional team meetings to share results and seek feedback
• Review and discuss scientific literature to identify assays to support validation of mechanism of action of target of interest
• Maintain cell lines in culture to be utilized in experiments
• Perform other responsibilities as assigned.

What minimum qualifications do we require?

• Rising Sophomore, Junior or Senior pursuing a degree in Biology, Biochemistry, Biomedical Engineering or a related field
• Interested in Biology drug discovery, cell and molecular biology
• Fundamental understanding of cellular biology
• Strong organizational and communication skills
• Experience with mammalian cell culture and aseptic techniques
• 0-2 years independent laboratory research
• Experience with basic lab techniques (pipetting, molecular biology, western blot, flow cytometry, ELISA)

What additional qualifications will make you a stronger candidate?

• Commitment to our Core Values: Patients First, Thoughtfulness, Urgency, Trust, Optimism

ONSITE EXPECTATIONS - onsite 5 days a week

DRESS CODE - Business casual:

• Slacks or business dress pants, khakis, chinos, dresses, dark jeans without holes
• Button-down shirts, sweaters, blouses, henleys or polo shirts
• Optional cardigans, blazers or sports coats (especially for the colder months)
• Closed-toed shoes such as loafers, Oxfords, boots, pumps or flats
• Simple, professional accessories such as scarves, belts or jewelry

PROGRAM DATES - Tuesday, May 27^th through Friday, August 15^th

PAY RANGE PER HOUR:

Why Blueprint?

At Blueprint Medicines, we achieve impactful results because of our global crew of compassionate innovators - the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action, we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights, which drives our success.

Equity, Diversity, Inclusion and Affirmative Action

At Blueprint Medicines, we foster a culture of equity, diversity and inclusion. A proud Equal Employment Opportunity and Affirmative Action employer, we consider all qualified applicants without regard to race, color, sex, gender identity or expression, sexual orientation, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, or any other characteristic protected under applicable law. We are also an E-Verify Employer. We will make reasonable accommodations, absent undue hardship, for qualified individuals with known disabilities. If you are an individual with a disability in need of an accommodation with the application or recruiting process, please reach out to TotalRewards@blueprintmedicines.com.

For more information, please see ourEEO-AA Policy Statement, the E-Verify Participation Poster, the Right to Work Poster, and/or theEEO Know Your Rights Poster, as well as ourPay Transparency Statement.

Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines, including bringing our medicine to patients with systemic mastocytosis (SM) in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including SM and chronic urticaria, breast cancer and other solid tumors.